Scisparc: mitocarex unveils groundbreaking discovery of small molecule structure in anti-cancer research

Mitocarex bio dedicates efforts to creating a predictive ai model to predict small molecules more efficiently tel aviv, israel, march 21, 2024 (globe newswire) -- scisparc ltd. (nasdaq: sprc) ("company" or "scisparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system, announced that mitocarex bio ltd.
SPRC Ratings Summary
SPRC Quant Ranking